Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Breastfeeding and infant nutrition" and "Society guideline links: Screening for depression".)
International
●International Neuromodulation Society and North American Neuromodulation Society (INS-NANS): Expert consensus panel review and recommendation for transcranial magnetic stimulation for pain, headache, and comorbid depression (2020)
●International Society for Nutritional Psychiatry Research (ISNPR): Practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder (2019)
●World Federation of Societies of Biological Psychiatry (WFSBP): Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder – An international consensus statement (2017)
●WFSBP: Consensus paper on genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response (2016)
●WFSBP: Guidelines for biological treatment of unipolar depressive disorders, part 2 – Maintenance treatment of major depressive disorder, update (2015)
●WFSBP: Guidelines for biological treatment of unipolar depressive disorders, part 1 – The acute and continuation treatment of unipolar depressive disorders, update (2013)
●WFSBP: Guidelines for biological treatment of unipolar depressive disorders in primary care (2007)
Canada
●Canadian Paediatric Society (CPS): Practice point on suicidal ideation and behaviour (2015, reaffirmed 2021)
●Choosing Wisely Canada: Don't routinely prescribe antidepressants as first-line treatment for depression comorbid with an active alcohol use disorder without first considering the possibility of a period of sobriety and subsequent reassessment for the persistence of depressive symptoms (2021)
●Choosing Wisely Canada: Don't routinely use antidepressants as first-line treatment for mild or subsyndromal depressive symptoms in adults (2021)
●Choosing Wisely Canada: Don't use SSRIs as the first-line intervention for mild to moderately depressed teens (2021)
●CPS: Position statement for the use of selective serotonin reuptake inhibitor medications for treatment of child and adolescent mental illness (2013, reaffirmed 2018)
●Canadian Network for Mood and Anxiety Treatments (CANMAT): Clinical guidelines for the management of adults with major depressive disorder – Introduction and methods (2016)
●CANMAT: Consensus recommendations for functional outcomes in major depressive disorder (2015)
●CANMAT: Recommendations for managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder (2012)
●CANMAT: Recommendations for the management of patients with mood disorders and comorbid conditions (2012)
United States
●US Department of Veterans Affairs/Department of Defense (VA/DoD): Clinical practice guidelines for the assessment and management of patients at risk for suicide (2019)
●American Academy of Pediatrics (AAP): Guidelines for adolescent depression in primary care (GLAD-PC) – Part I: Practice preparation, identification, assessment, and initial management (2018)
●AAP: Guidelines for adolescent depression in primary care (GLAD-PC) – Part II: Treatment and ongoing management (2018)
●American Psychiatric Association (APA): Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression (2018)
●American Heart Association (AHA)/American Stroke Association (ASA): Scientific statement on poststroke depression (2016)
●VA/DoD: Clinical practice guideline for the management of major depressive disorder (2016)
●American Society of Clinical Oncology (ASCO): Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer – Guideline adaptation (2014)
●APA: Practice guideline for the treatment of patients with major depressive disorder, 3rd edition (2010)
●American Academy of Family Physicians (AAFP): Guideline for the detection and management of post-myocardial infarction depression (2009)
●US Department of Health and Human Services (HHS): Managing depressive symptoms in substance abuse clients during early recovery – A treatment improvement protocol (2008)
●American Academy of Child and Adolescent Psychiatry (AACAP): Practice parameter for the assessment and treatment of children and adolescents with depressive disorders (2007)
●Evaluation of Genomic Applications in Practice and Prevention (EGAPP): Recommendations for testing cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors (2007)
Europe
●European Psychiatric Association (EPA): Guidance on physical activity as a treatment for severe mental illness (2018)
●EPA: Guidance on psychotherapy in chronic depression across Europe (2016)
●EPA: Guidance on suicide treatment and prevention (2011)
●EPA: Position statement on the value of antidepressants in the treatment of unipolar depression (2011)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on depression in adults – Treatment and management (2022)
●NICE: Guideline on depression in children and young people – Identification and management (2019)
●NICE: Guideline on preventing suicide in community and custodial settings (2018)
●British Association for Psychopharmacology (BAP): Evidence-based guidelines for treating depressive disorder with antidepressants – A revision of the 2008 guidelines (2015)
●NICE: Quality standard on depression in children and young people (2013)
●NICE: Quality standard on depression in adults (2011)
●NICE: Clinical guideline on depression in adults with a chronic physical health problem – Recognition and management (2009)
Australia-New Zealand
●Royal Australian and New Zealand College of Psychiatrists (RANZCP): Clinical practice guidelines for mood disorders (2020)
●RANZCP: Professional practice guidelines for the administration of electroconvulsive therapy (2019)
●Australian National Health and Medical Research Council (NHMRC): Clinical focus on screening, referral and treatment for depression in patients with coronary heart disease (2013)
